Celldex Therapeutics buy BiotechBee
Start price
07.09.22
/
80%
€29.80
Target price
31.12.25
€50.00
Performance (%)
23.49%
Price
15.05.24
€37.00
Summary
This prediction is currently active. The BUY prediction by BiotechBee currently has a performance of 23.49%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Celldex Therapeutics | -3.646% | -3.646% | 20.915% |
iShares Core DAX® | 1.851% | 5.158% | 17.711% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% |
According to BiotechBee what are the pros and cons of Celldex Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Celldex Therapeutics diskutieren
Buy mit Kursziel 50,0